Ignore the noise in GLP-1 stocks. Find the best value instead.

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...

Roche (RHHBY) is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker ...

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

During a White House meeting with Irish Taoiseach Micheál Martin, Trump accused Ireland of stealing US pharmaceutical companies and their associated tax revenue ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

Indiana University Health is building a new hospital on a 44-acre campus in Indianapolis. The facility will consolidate the ...

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

As part of the deal, which will be completed later this year, the Chicago-based pharmacy chain will sell its VillageMD unit. Other pharmaceutical news is about Cost Plus Drug Co., Eli Lilly, and more.

House Bill 1879 passed unanimously March 4 on a 95-0 vote, according to the chamber's website. State senators will now ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.